Lupus Research Alliance Accepting LOIs for Distinguished Innovator Award in Lupus and Autoimmunity

The Lupus Research Alliance works to fund the most innovative lupus research, foster diverse scientific talent, stimulate collaborations, and drive discovery toward better diagnostics, improved treatments, and, ultimately, a cure for lupus.

To advance its mission, the alliance welcomes applications for its Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity. Through the program, grants of up to $1 million over four years will be awarded in support of bold and paradigm-shifting ideas that could lead to groundbreaking discoveries in lupus research. Research conducted under the program is expected to be highly innovative and address the fundamental causes of systemic lupus erythematosus, providing new directions toward a cure.

LRA welcomes novel, hypothesis- or discovery-driven proposals using clinically-relevant models in lupus research. The proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a cure, prevention, or highly effective therapy.

To be eligible, applicants must hold a faculty position at the assistant professor level or above at an academic institution. LRA does not impose geographic restriction on its applicants and researchers working outside the U.S. are encouraged to apply.

Letters of Intent are due June 1. Upon review, selected applicants will be invited to submit a full application by September 3, 2021.

See the Lupus Research Alliance website for complete program guidelines and application instructions.

View another RFP related to medical research

Deadline: April 21, 2021